Condensed Consolidated Statements Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2021		50,313,452
Balance at beginning of period at Dec. 31, 2021	$ 239,209	$ 50	$ 257,144	$ (402)	$ (17,583)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Options exercised for common stock (in shares)		322,882
Options exercised for common stock	345	$ 1	344
Shares issued under Employee Stock Purchase Plan (in shares)		54,808
Shares issued under Employee Stock Purchase Plan	3,427		3,427
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for taxes (in shares)		31,763
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for taxes	(1,624)		(1,624)
Issuance of common stock in public offering, net of issuance costs (in shares)		2,300,000
Issuance of common stock in public offering, net of issuance costs	174,394	$ 2	174,392
Share-based compensation expense	6,555		6,555
Other comprehensive income (loss)	(365)			(365)
Net income (loss)	(3,129)				(3,129)
Balance at end of period (in shares) at Mar. 31, 2022		53,022,905
Balance at end of period at Mar. 31, 2022	418,812	$ 53	440,238	(767)	(20,712)
Balance at beginning of period (in shares) at Dec. 31, 2021		50,313,452
Balance at beginning of period at Dec. 31, 2021	239,209	$ 50	257,144	(402)	(17,583)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(13,316)
Balance at end of period (in shares) at Jun. 30, 2022		53,305,825
Balance at end of period at Jun. 30, 2022	413,778	$ 53	445,807	(1,183)	(30,899)
Balance at beginning of period (in shares) at Mar. 31, 2022		53,022,905
Balance at beginning of period at Mar. 31, 2022	418,812	$ 53	440,238	(767)	(20,712)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Options exercised for common stock (in shares)		228,313
Options exercised for common stock	156		156
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for taxes (in shares)		54,607
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for taxes	(1,751)		(1,751)
Share-based compensation expense	7,164		7,164
Other comprehensive income (loss)	(416)			(416)
Net income (loss)	(10,187)				(10,187)
Balance at end of period (in shares) at Jun. 30, 2022		53,305,825
Balance at end of period at Jun. 30, 2022	$ 413,778	$ 53	445,807	(1,183)	(30,899)
Balance at beginning of period (in shares) at Dec. 31, 2022	54,021,656	54,021,656
Balance at beginning of period at Dec. 31, 2022	$ 417,002	$ 54	462,949	849	(46,850)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Options exercised for common stock (in shares)		209,966
Options exercised for common stock	226		226
Shares issued under Employee Stock Purchase Plan (in shares)		86,051
Shares issued under Employee Stock Purchase Plan	4,172		4,172
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for taxes (in shares)		2,766,043
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for taxes	(1,929)	$ 3	(1,932)
Share-based compensation expense	10,339		10,339
Other comprehensive income (loss)	(856)			(856)
Net income (loss)	(2,218)				(2,218)
Balance at end of period (in shares) at Mar. 31, 2023		57,083,716
Balance at end of period at Mar. 31, 2023	$ 426,736	$ 57	475,754	(7)	(49,068)
Balance at beginning of period (in shares) at Dec. 31, 2022	54,021,656	54,021,656
Balance at beginning of period at Dec. 31, 2022	$ 417,002	$ 54	462,949	849	(46,850)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ (133)
Balance at end of period (in shares) at Jun. 30, 2023	57,266,455	57,266,455
Balance at end of period at Jun. 30, 2023	$ 435,645	$ 57	483,752	(1,181)	(46,983)
Balance at beginning of period (in shares) at Mar. 31, 2023		57,083,716
Balance at beginning of period at Mar. 31, 2023	426,736	$ 57	475,754	(7)	(49,068)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Options exercised for common stock (in shares)		81,712
Options exercised for common stock	214		214
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for taxes (in shares)		101,027
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for taxes	(2,569)		(2,569)
Share-based compensation expense	10,353		10,353
Other comprehensive income (loss)	(1,174)			(1,174)
Net income (loss)	$ 2,085				2,085
Balance at end of period (in shares) at Jun. 30, 2023	57,266,455	57,266,455
Balance at end of period at Jun. 30, 2023	$ 435,645	$ 57	$ 483,752	$ (1,181)	$ (46,983)